Needham analyst David Saxon has maintained their neutral stance on NVST stock, giving a Hold rating today.
David Saxon has given his Hold rating due to a combination of factors that were highlighted during Envista Holdings’ Capital Markets Day. The company presented a strategic plan that includes a focus on its orthodontics and implants segments, which are expected to benefit from a gradually improving market and effective execution strategies. Additionally, while earnings growth is anticipated to be more robust in the initial years due to current cost-cutting measures, the overall valuation of Envista Holdings appears to be reasonable when considering its financial standing. As a result, Saxon believes that maintaining a Hold rating is appropriate given the current circumstances.
According to TipRanks, Saxon is an analyst with an average return of -0.5% and a 36.36% success rate. Saxon covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, Staar Surgical, and Globus Medical.
In another report released today, Morgan Stanley also maintained a Hold rating on the stock with a $19.00 price target.